PNC Financial Services Group
BNTC icon

PNC Financial Services Group’s Benitec Biopharma BNTC Stock Holding History

PNC Financial Services Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$960 Sell
96
-138
-59% -$1.69K ﹤0.01% 5003
2026
Q2 		$3.13K Buy
234
+38
+19% +$451 ﹤0.01% 4547
2026
Q1 		$2.09K Buy
196
+49
+33% +$567 ﹤0.01% 4566
2025
Q4 		$1.98K Buy
147
+142
+2,840% +$1.96K ﹤0.01% 4531
2025
Q3 		$70 Buy
+5
New +$64 ﹤0.01% 5018

Other funds holding BNTC

Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

PNC Financial Services Group's BNTC Position: Q3 2026 in Review

PNC Financial Services Group reduced its Benitec Biopharma (BNTC) stake by 59% in Q3 2026, selling an estimated $1.69K and leaving 96 shares worth $960. The position accounts for ﹤0.01% of the portfolio, ranked #5003.

PNC Financial Services Group first reported a position in BNTC in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.13K in Q2 2026. 32 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • PNC Financial Services Group held 96 shares of Benitec Biopharma worth $960 as of Q3 2026.
  • PNC Financial Services Group sold 138 Benitec Biopharma shares in Q3 2026, an estimated $1.69K.
  • Benitec Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5003 holding.
  • PNC Financial Services Group first reported a position in Benitec Biopharma in Q3 2025 and has held it in 5 quarters since.
  • PNC Financial Services Group's Benitec Biopharma position peaked at $3.13K in Q2 2026.
  • 32 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.